Association of common variants of vascular endothelial growth factor and interleukin-18 genes with allograft survival in renal transplant recipients of north India

DNA and Cell Biology

Volumn 30, Issue 5, 2011, Pages 309-315

  Mittal, Rama Devi ^a   Srivastava, Priyanka ^a   Singh, Vibha ^a   Jaiswal, Praveen ^a   Kapoor, Rakesh ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18; VASCULOTROPIN;

ADULT; AGED; ARTICLE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GRAFT RECIPIENT; GRAFT SURVIVAL; HETEROZYGOTE; HUMAN; INDIA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GRAFT SURVIVAL; HAPLOTYPES; HUMANS; INDIA; INTERLEUKIN-18; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 79955772648     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2010.1138     Document Type: Article

References (26)

1. Affleck, D.G., Bull, D.A., et al. (2001). Interleukin-18 production following murine cardiac transplantation: correlation with histologic rejection and the induction of INF-gamma. J Interferon Cytokine Res 21, 1-9. (Pubitemid 32106085)
2. Awata, T., Inoue, K., et al. (2002). A common polymorphism in the 50-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51, 1635-1639. (Pubitemid 34826636)
3. Cosio, F.G., Pelletier, R.P., et al. (1997). Impact of acute rejection and early allograft function on renal allograft survival. Transplantation 63, 1611-1615. (Pubitemid 27265503)
4. Freeman, M.R., Schneck, F.X., et al. (1995). Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res 55, 4140-4145.
5. Gracie, J.A., Forsey, R.J., et al. (1999). A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 104, 1393-1401.
6. Itaya, H., Imaizumi, T., et al. (2001). Expression of vascular endothelial growth factor in human monocyte/macrophages stimulated with lipopolysaccharide. Thromb Haemost 85, 171-176. (Pubitemid 32050960)
7. Joosten, L.A., van De Loo, F.A., et al. (2000). An IFN-gammaindependent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. J Immunol 165, 6553-6558.
8. Jose, M.D., Ikezumi, Y., et al. (2003). Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 76, 1015-1022. (Pubitemid 37280827)
9. Kawai, Y., Sakano, S., et al. (2007). Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas. Eur Urol 52, 1147-1455.
10. Kim, I., Moon, S.O., et al. (2001). Angiopoietin-1 reduces VEGFstimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res 89, 477-479. (Pubitemid 34132640)
11. Komai-Koma, M., Gracie, J.A., et al. (2003). Chemoattraction of human T cells by IL-18. J Immunol 170, 1084-1090. (Pubitemid 36070565)
12. Koukourakis, M.I., Papazoglou, D., et al. (2004). VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46, 293-298. (Pubitemid 39487303)
13. Marumo, T., Schini-Kerth, V.B., et al. (1999). Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 48, 1131-1137. (Pubitemid 29226362)
14. McCarron, S.L., Edwards, S., et al. (2002). Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 62, 3369-3372. (Pubitemid 34651380)
15. Miller, S.A., Dykes, D.D., et al. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16, 1215.
16. Mohammadi, M., Ollier, W.E., et al. (2003). A functional association study of VEGF gene promoter polymorphisms with VEGF expression by stimulated PBM cells. Hum Immunol 64, 125.
17. Nong, L.G., Luo, B., et al. (2009). Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population. DNA Cell Biol 28, 507-513.
18. Racusen, L.C., Solez, K., et al. (1999). The Banff 97 working classification of renal allograft pathology. Kidney Int 55, 713-723. (Pubitemid 29082898)
19. Ruiz, M.T., Biselli, P.M., et al. (2010). Genetic variability of vascular endothelial growth factor and prognosis of head and neck cancer in a Brazilian population. Braz J Med Biol Res 43, 127-133.
20. Rush, D., Jeffery, J., et al. (1996). Effect of subclinical rejection on renal allograft histology and function at 6 months. Transplant Proc 28, 494-495. (Pubitemid 26076590)
21. Shahbazi, M., Fryer, A.A., et al. (2002). Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13, 260-264. (Pubitemid 34042036)
22. Tischer, E., Mitchell, R., et al. (1991). The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266, 11947-11954.
23. Vincenti, V., Cassano, C., et al. (1996). Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93, 1493-1495. (Pubitemid 26115412)
24. Watson, C.J., Webb, N.J., et al. (2000). Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12, 1232-1235. (Pubitemid 30611801)
25. Wyburn, K., Wu, H., et al. (2005). Macrophage-derived interleukin- 18 in experimental renal allograft rejection. Nephrol Dial Transplant 20, 699-706. (Pubitemid 40520645)
26. Yi, S., Hawthorne, W.J., et al. (2003). T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol 170, 2750-2758. (Pubitemid 36245670)